Effect of β-adrenoreceptor blockade with nadolol: On the duration of local anesthesia

Journal of the American Dental Association

Volumn 130, Issue 12, 1999, Pages 1773-1780

  Zhang, Charles ^a   Banting, David W ^a   Gelb, Adrian W ^a   Hamilton, John T ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LIDOCAINE; LOCAL ANESTHETIC AGENT; NADOLOL; VASOCONSTRICTOR AGENT;

ANESTHETIC RECOVERY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DENTAL ANESTHESIA; DOUBLE BLIND PROCEDURE; DRUG POTENTIATION; HUMAN; MALE; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; TIME;

ADRENERGIC BETA-ANTAGONISTS; ANESTHESIA RECOVERY PERIOD; ANESTHESIA, DENTAL; ANESTHETICS, LOCAL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG SYNERGISM; EPINEPHRINE; HUMANS; LIDOCAINE; MALE; NADOLOL; TIME FACTORS; VASOCONSTRICTOR AGENTS;

EID: 0033250602     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.1999.0136     Document Type: Article

References (30)

1. Desjardins PJ. The top prescription drugs and how they affect your dental practice. Compend Cont Educ Dent 1990;13(9):740-56.
2. Hargreaves KM, Neidle EA. Introduction to autonomic nervous system drugs. In: Yagiela JA, Neidle EA, Dowd FJ, eds. Pharmacology and therapeutics for dentistry. 4th ed. St. Louis: Mosby; 1998;73, 78.
3. Dale HH. On some physiological actions of ergot. J Physiol (Lond) 1906;34:163-206.
4. Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG Jr. Differentiation of receptor systems activated by sympathomimetic amines. Nature 1967;214:597-8.
5. Haas DA, Lennon D. Local anesthetic use by dentists in Ontario. J Can Dent Assoc 1995;21:297-304.
6. U.S. Pharmacopeial Convention. USP DI. Vol. 1: Drug information for the health care professional. 18th ed. Rockville, Md.: United States Pharmacopeial Convention; 1998.
7. Jastak JT, Yagiela JA, Donaldson D. Pharmacology of vasoconstrictors. In: Jastak JT, Yagiela JA, Donaldson D, eds. Local anesthesia of the oral cavity. Philadelphia: W.B. Saunders Co.; 1995:61-85.
8. Malamed SF. Handbook of local anaesthesia. 3rd ed. St. Louis: Mosby; 1990:46-75.
9. Goulet JP, Perusse R, Turcotte JY. Contraindications to vasoconstrictors in dentistry: Part III. Oral Surg Oral Med Oral Pathol 1992;74:692-7.
10. Hansbrough JF, Near A. Propranololepinephrine antagonism with hypertension and stroke. Ann Intern Med 1980;92:717.
11. Frishman WH. β-adrenergic receptor blockers: adverse effects and drug interactions. Hypertension 1988;11(3 part 2):21-9.
12. Kevorkian G. Adverse sequelae with combined use of beta-blockers and epinephrine. Gen Dent 1987;35:298-300.
13. Foster CA, Aston SJ. Propranolol-epinephrine interaction: a potential disaster. Plast Reconstr Surg 1983;72:74-8.
14. Fiset L, Ramsay D, Milgrom P, Weinstein P. The effects of lidocaine with epinephrine on fear-related arousal among dental phobics. Anesth Prog 1986;33:225-9.
15. Zhang C, Gelb AW, Hamilton JT. A reassessment of dental vasoconstrictors: a quantitative and comparative evaluation under simulated therapeutic challenges. Presented at: 1994 CDA/Dentsply Student Clinician Program, FDI 82nd World Dental Congress; Oct. 4, 1994, Vancouver, British Columbia, Canada.
16. Wood AJ. Pharmacologic differences between beta-blockers. Am Heart J 1984;108:1070-6.
17. Kostis JB, Lacy CR, Kreiger SD, Cosgrove NM. Atenolol, nadolol and pindolol in angina pectoris on effort: effect of pharmacokinetics. Am Heart J 1984;108(4 part 2):1131-5.
18. Wilkinson R, Burr WA. A comparison of propranolol and nadolol pharmacokinetics and clinical effects in thyrotoxicosis. Am Heart J 1984;108(4 part 2):1160-7.
19. Duchin KL, Stern MA, Willard DA, McKinstry DN. Comparison of kinetic interactions of nadolol and of propranolol with cimetidine. Am Heart J 1984;108(4 part 2):1084-6.
20. Man in't Veld AJ. Vasodilation, not cardiodepression, underlies the antihypertensive effect of beta-adrenoceptor antagonists. Am J Cardiol 1991;67:13B-7B.
21. Bulbring E, Tomita T. Catecholamine action on smooth muscle. Pharmacol Rev 1987;39:49-96.
22. Prehn JL, Bevan JA. Facial vein of the rabbit: intracellularly recorded hyperpolarization of smooth muscle cells induced by β-adrenergic receptor stimulation. Circ Res 1983;52:465-70.
23. Kim S. Regulation of pulpal blood flow. J Dent Res 1985;64:590-6.
24. Tonder KJ. Blood flow and vascular pressure in the dental pulp. Acta Odontol Scand 1980;38:135-44.
25. Becker DE. Drug interactions in dental practice: a summary of facts and controversies. Compend Cont Educ Dent 1994;15:1228-44.
26. Nellen M. Withdrawal of propranolol and myocardial infarction. Lancet 1973;1:558.
27. Miller RR, Olson HG, Amsterdam EA, et al. Propranolol-withdrawal rebound phenomenon. N Engl J Med 1975;293:416-8.
28. Alexander GD. Dangers of propranolol withdrawal prior to local anesthesia with epinephrine. Arch Otolaryngol 1985;111:280.
29. Mito RS, Yagiela JA. Hypertensive response to levonordefrin in a patient receiving propranolol: report of case. JADA 1988;116:55-7.
30. Roy RC, Weeks DB. Otolaryngologists using local anesthetics containing epinephrine (letter). Arch Otolaryngol 1985;111:280-1.